Global Graft Versus Host Disease Treatment Market 2022-2027:Annual Growth of 9.21% Driven by Key Players GlaxoSmithKline, Pfizer, Merck
30 août 2022 05h28 HE | Research and Markets
Dublin, Aug. 30, 2022 (GLOBE NEWSWIRE) -- The "Global Graft Versus Host Disease Treatment Market (2022-2027) by Disease Type, Product, Geography, Competitive Analysis and the Impact of Covid-19 with...
Global Corneal Transplantation Market Forecast to 2028 - COVID-19 Impact and Analysis
22 mars 2022 07h18 HE | Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Corneal Transplantation Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Indication End User" report has been added to...
immucor.jpg
Immucor Announces New Innovations in Transplant Diagnostics
04 mars 2022 13h18 HE | Immucor, Inc.
NORCROSS, Ga., March 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion and transplantation diagnostics announced two additions to its transplant diagnostics portfolio,...
Celebrate Mother’s Day With the Gift of Life-Saving Cord Blood Donation
30 avr. 2021 16h59 HE | Parent’s Guide to Cord Blood Foundation
BROOKEVILLE, Md., April 30, 2021 (GLOBE NEWSWIRE) -- As we look toward celebrating Mother’s Day on May 9, we recognize all of the very many ways moms love their children, provide endless hours of...
22157.jpg
Global Cord Blood Banking Industry Report 2021: Holding Companies are Emerging as a Global Theme
11 janv. 2021 07h38 HE | Research and Markets
Dublin, Jan. 11, 2021 (GLOBE NEWSWIRE) -- The "Global Cord Blood Banking Industry Report 2021" report has been added to ResearchAndMarkets.com's offering. From the early 1900s through the...
22157.jpg
Global Cord Blood Banking Industry Report 2020: Trends, Expansion Technologies, Key Strategies, Regional Insights
31 août 2020 06h59 HE | Research and Markets
Dublin, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The "Global Cord Blood Banking Industry Report 2020" report has been added to ResearchAndMarkets.com's offering.This report presents the number of cord...
Reports and Data.jpeg-01
Acute Myeloid Leukemia Therapeutics Market To Reach USD 3.56 Billion By 2027 | Reports And Data
22 juil. 2020 15h04 HE | Reports and Data
New York, July 22, 2020 (GLOBE NEWSWIRE) -- Market Size – USD 1.46 Billion in 2019, Market Growth - CAGR of 13.1%, Market Trends – Implementing various growth strategies in therapeutics. New York,...
Bellicum Logo.jpg
Bellicum Pharmaceuticals Presents Encouraging Preclinical Data for GoCAR-NK Cell Program at Society for Immunotherapy of Cancer Annual Meeting
08 nov. 2019 07h00 HE | Bellicum Pharmaceuticals, Inc.
iMC activation enhances innate NK cell cytotoxicity against tumor cell lines in vitro MC activity enhances the efficacy of CAR-NK cells against hematological and solid tumor models MC signaling...
Bellicum Logo.jpg
Bellicum Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Operational Update
06 nov. 2019 16h15 HE | Bellicum Pharmaceuticals, Inc.
Raised gross proceeds of $69.6 million from public offering and private placement option fee Narrowed strategic focus to core GoCAR-T® cell therapy programs Cost saving initiatives underway to...
Bellicum Logo.jpg
Bellicum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
30 sept. 2019 16h07 HE | Bellicum Pharmaceuticals, Inc.
HOUSTON, Sept. 30, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood...